Prof. Dr. Jens Huober
chief physician
Brustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?
Jörger M, Thürlimann B, Huober J. Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?. Ann Oncol 2010; 22:17-23.
Jun 20, 2010Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?
Jun 20, 2010Ann Oncol 2010; 22:17-23
Jörger Markus, Thürlimann Beat, Huober Jens
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study
Moebus V, Konecny G, Kreienberg R, Hinke A, Runnebaum I, von Minckwitz G, Harbeck N, Huober J, Schneeweiss A, Nitz U, Kuhn W, Kurbacher C, Thomssen C, du Bois A, Lueck H, Jackisch C, Untch M. Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. J Clin Oncol 2010; 28:2874-80.
Jun 10, 2010Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study
Jun 10, 2010J Clin Oncol 2010; 28:2874-80
Moebus Volker, Konecny Gottfried E, Kreienberg Rolf, Hinke Axel, Runnebaum Ingo B, von Minckwitz Gunter, Harbeck Nadia, Huober Jens, Schneeweiss Andreas, Nitz Ulrike, Kuhn Walther, Kurbacher Christian, Thomssen Christoph, du Bois Andreas, Lueck Hans-Joachim, Jackisch Christian, Untch Michael
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial
Riethdorf S, von Minckwitz G, Untch M, Eidtmann H, Tesch H, Holms F, Hilfrich J, Schrader I, Fehm T, Huober J, Roller M, Komor M, Loibl S, Rau T, Zhang L, Müller V, Pantel K. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin Cancer Res 2010; 16:2634-45.
Apr 20, 2010Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial
Apr 20, 2010Clin Cancer Res 2010; 16:2634-45
Riethdorf Sabine, von Minckwitz Gunter, Untch Michael, Eidtmann Holger, Tesch Hans, Holms Frank, Hilfrich Jörn, Schrader Iris, Fehm Tanja, Huober Jens, Roller Marc, Komor Martina, Loibl Sibylle, Rau Thomas, Zhang Liling, Müller Volkmar, Pantel Klaus
Bone targeted therapy in breast cancer: present and future
Huober J, Thürlimann B. Bone targeted therapy in breast cancer: present and future. Crit Rev Oncol Hematol 2010; 74S1:S7-S10.
Apr 1, 2010Bone targeted therapy in breast cancer: present and future
Apr 1, 2010Crit Rev Oncol Hematol 2010; 74S1:S7-S10
Huober Jens, Thürlimann Beat
Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study
von Minckwitz G, Kühn T, du Bois A, Blohmer J, Thomssen C, Dan Costa S, Jackisch C, Kaufmann M, Mehta K, Hanusch C, Gerber B, Rezai M, Loibl S, Fasching P, Huober J, Tesch H, Bauerfeind I, Hilfrich J, Eidtmann H, Untch M. Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study. J Clin Oncol 2010; 28:2015-23.
Mar 22, 2010Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study
Mar 22, 2010J Clin Oncol 2010; 28:2015-23
von Minckwitz Gunter, Kühn Thorsten, du Bois Andreas, Blohmer Jens-Uwe, Thomssen Christoph, Dan Costa Serban, Jackisch Christian, Kaufmann Manfred, Mehta Keyur, Hanusch Claus, Gerber Bernd, Rezai Mahdi, Loibl Sibylle, Fasching Peter A, Huober Jens, Tesch Hans, Bauerfeind Ingo, Hilfrich Jörn, Eidtmann Holger, Untch Michael
Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study
Untch M, Kühn T, du Bois A, Blohmer J, Thomssen C, Dan Costa S, Jackisch C, Kaufmann M, Mehta K, Hanusch C, Gerber B, Rezai M, Loibl S, Fasching P, Huober J, Tesch H, Bauerfeind I, Hilfrich J, Eidtmann H, von Minckwitz G. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study. J Clin Oncol 2010; 28:2024-31.
Mar 22, 2010Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study
Mar 22, 2010J Clin Oncol 2010; 28:2024-31
Untch Michael, Kühn Thorsten, du Bois Andreas, Blohmer Jens-Uwe, Thomssen Christoph, Dan Costa Serban, Jackisch Christian, Kaufmann Manfred, Mehta Keyur, Hanusch Claus, Gerber Bernd, Rezai Mahdi, Loibl Sibylle, Fasching Peter A, Huober Jens, Tesch Hans, Bauerfeind Ingo, Hilfrich Jörn, Eidtmann Holger, von Minckwitz Gunter
Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer
Huober J, Schoch O, Templeton A, Spirig C, Thürlimann B. Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer. Chemotherapy 2010; 56:69-70.
Feb 8, 2010Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer
Feb 8, 2010Chemotherapy 2010; 56:69-70
Huober Jens, Schoch Otto, Templeton Arnoud, Spirig Christian, Thürlimann Beat
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Huober J, Lück H, Goehler T, Gerhardt S, Wischnik A, Schmidt M, Neise M, Nusch A, Fett W, Rost A. A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer. BMC cancer 2010; 10:2.
Jan 1, 2010A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Jan 1, 2010BMC cancer 2010; 10:2
Huober Jens, Lück Hans-Joachim, Goehler Thomas, Gerhardt Steffen, Wischnik Arthur, Schmidt Marcus, Neise Michael, Nusch Arnd, Fett Werner, Rost Andreas
Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data
Costa S, Tesch H, Gerber B, Baumann K, Thomssen C, Breitbach G, Ibishi S, Jackisch C, Mehta K, Weiss E, Ataseven B, Loibl S, Kaufmann M, Zahm D, Hilfrich J, Huober J, Eidtmann H, du Bois A, Blohmer J, von Minckwitz G. Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010; 28:83-91.
Jan 1, 2010Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data
Jan 1, 2010Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010; 28:83-91
Costa Serban Dan, Tesch Hans, Gerber Bernd, Baumann Klaus H, Thomssen Christoph, Breitbach Georg Peter, Ibishi Shaip, Jackisch Christian, Mehta Keyur, Weiss Erich, Ataseven Beyhan, Loibl Sibylle, Kaufmann Manfred, Zahm Dirk-Michael, Hilfrich Jörn, Huober Jens, Eidtmann Holger, du Bois Andreas, Blohmer Jens-Uwe, von Minckwitz Gunter
The Role of Combination Chemotherapy in the Treatment of Patients with Metastatic Breast Cancer
Huober J, Thürlimann B. The Role of Combination Chemotherapy in the Treatment of Patients with Metastatic Breast Cancer. Breast Care (Basel) 2009; 4:367-372.
Dec 16, 2009The Role of Combination Chemotherapy in the Treatment of Patients with Metastatic Breast Cancer
Dec 16, 2009Breast Care (Basel) 2009; 4:367-372
Huober Jens, Thürlimann Beat
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies
du Bois A, Huober J, Stopfer P, Pfisterer J, Wimberger P, Loibl S, Reichardt V, Harter P. A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies. Ann Oncol 2009; 21:370-5.
Nov 4, 2009A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies
Nov 4, 2009Ann Oncol 2009; 21:370-5
du Bois A, Huober Jens, Stopfer P, Pfisterer J, Wimberger P, Loibl S, Reichardt V L, Harter P
Adjuvant! When the new world meets the old world
Huober J, Thürlimann B. Adjuvant! When the new world meets the old world. The Lancet 2009; 10:1028-9.
Nov 1, 2009Adjuvant! When the new world meets the old world
Nov 1, 2009The Lancet 2009; 10:1028-9
Huober Jens, Thürlimann Beat
Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis
Harter P, Loibl S, Meier W, Huober J, Fink D, Schroeder W, Muenstedt K, Schmalfeldt B, Emons G, Burges A, Hasenburg A, Hahmann M, Lueck H, Poelcher M, Wimberger P, Ortmann O, Canzler U, Richter B, Wagner U, du Bois A. Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of surgical oncology 2009; 16:1324-30.
May 1, 2009Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis
May 1, 2009Annals of surgical oncology 2009; 16:1324-30
Harter P, Loibl S, Meier W, Huober Jens, Fink D, Schroeder W, Muenstedt K, Schmalfeldt B, Emons G, Burges A, Hasenburg A, Hahmann M, Lueck H J, Poelcher M, Wimberger P, Ortmann O, Canzler U, Richter B, Wagner U, du Bois A
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
Chan S, Frimodt-Moller B, Vaury A, Carrasco E, Jones A, Harrison M, Antón A, Mayordomo J, Kreienberg R, du Bois A, Llombart A, Lluch A, Schneeweiss A, Tubiana-Hulin M, Delozier T, Huober J, Romieu G, Fumoleau P. Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:1753-60.
Apr 10, 2009Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
Apr 10, 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:1753-60
Chan Stephen, Frimodt-Moller Bente, Vaury A Thareau, Carrasco Eva, Jones Alison, Harrison Mark, Antón Antonio, Mayordomo Jose Ignacio, Kreienberg Rolf, du Bois Andreas, Llombart Antonio, Lluch Ana, Schneeweiss Andreas, Tubiana-Hulin Michele, Delozier Thierry, Huober Jens, Romieu Gilles, Fumoleau Pierre
Adjuvante endokrine Therapie in der Prämenopause
Huober J, Scharl T. Adjuvante endokrine Therapie in der Prämenopause - Aktuelle Empfehlungen zur Therapie primärer und fortgeschrittener Mammakarzinome. In: Kommission Mamma der AGO, vertreten durch Thomssen C (Hrsg.). 3. AuflageMünchen, Wien, New York: Zuckschwerdt Verlag, 2009. pp. 1-9.
Jan 1, 2009Adjuvante endokrine Therapie in der Prämenopause
Jan 1, 2009Zuckschwerdt Verlag
Huober Jens, Scharl T
Ovarialkarzinom
Huober J, Grischke E, Marme A. Ovarialkarzinom. In: Die Onkologie (Hrsg. Hiddemann W, Bartram C.R.). 2. AuflageHeidelberg: Springer Medizin Verlag, 2009. pp. 990-1003.
Jan 1, 2009Ovarialkarzinom
Jan 1, 2009Springer Medizin Verlag
Huober Jens, Grischke E-M, Marme A.
Interdisziplinary S2K guideline on the diagnosis and treatment of cervical carcinoma
Beckmann M, Malmann P, Blohmer J, Huober J, Weidner N. Interdisziplinary S2K guideline on the diagnosis and treatment of cervical carcinoma. J Cancer Res Clin Oncol 2009; 135:1197-1206.
Jan 1, 2009Interdisziplinary S2K guideline on the diagnosis and treatment of cervical carcinoma
Jan 1, 2009J Cancer Res Clin Oncol 2009; 135:1197-1206
Beckmann M, Malmann P, Blohmer J, Huober Jens, Weidner N
Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany
Pfisterer J, Arnold N, Burchardi N, Schmalfeldt B, Huober J, Harter P, Kommoss F, Bentz E, du Bois A, Hilpert F. Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009; 19:109-15.
Jan 1, 2009Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany
Jan 1, 2009International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009; 19:109-15
Pfisterer Jacobus, Arnold Norbert, Burchardi Nicole, Schmalfeldt Barbara, Huober Jens, Harter Philipp, Kommoss Friedrich, Bentz Eva-Katrin, du Bois Andreas, Hilpert Felix
Polychemotherapy in metastatic breast cancer - pro
Huober J, Thürlimann B. Polychemotherapy in metastatic breast cancer - pro. Breast Care 2009; 4:367-372.
Jan 1, 2009Polychemotherapy in metastatic breast cancer - pro
Jan 1, 2009Breast Care 2009; 4:367-372
Huober Jens, Thürlimann Beat
Dose-Dense Therapy
Untch M, Bergh J, Citron M, Hudis C, Huober J, Möbus V, Steger G. Dose-Dense Therapy. Breast Care (Basel) 2008; 3:134-138.
Apr 28, 2008Dose-Dense Therapy
Apr 28, 2008Breast Care (Basel) 2008; 3:134-138
Untch Michael, Bergh Jonas, Citron Mark, Hudis Clifford A, Huober Jens, Möbus Volker, Steger Günter